New York – United States
Global Precision Medicine Market research report involves major parameters namely market analysis, market definition, market segmentation, key developments in the market, competitive analysis, and research methodology. Depending on client’s requirements, massive business, product and market related information is brought together via this report that eventually helps businesses create better strategies. The report has across-the-board and comprehensive market insights which are based on business intelligence. No stone is left unturned while researching and analyzing data to prepare market research report like this one and the others. The persuasive Global Precision Medicine report helps unearth the general market conditions, existing trends and tendencies.
Precision medicine is the latest disease prevention and treatment approach that is gaining much popularity. Several initiatives, such as Precision Medicine Initiative (PMI), were announced in 2015, with more than one million volunteers taking place to apply precision medicine to all disorders. Different types of innovation and the wide availability of new technology are other major factors for the market’s growth.
Data Bridge Market Research analyses that the precision medicine market, which was USD 7.33 billion in 2022, would rise to USD 114.54 billion by 2030 and is expected to undergo a CAGR of 12.6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Get a PDF Sample of the Global Precision Medicine @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-precision-medicine-market&Shri
Precision medicine is a type of medical approach for disease prevention and diagnosis which is based on environmental, genetic, and behavioral variability. It helps predict illness susceptibility, diagnosis and progression, and prescription medicine. Precision medicine is also frequently used to identify chromosomal abnormalities in the fetus and cancer, direct therapy for chronic diseases, and identify the risk of passing genetic problems by minimizing pharmaceutical clinical studies’ time, expense, and failure rate.
Drivers
Increasing Rate of CNS Disorders
Several diseases, such as Alzheimer’s disease, epilepsy, multiple sclerosis, and other CNS disorders, affect millions of individuals globally. Epilepsy affects more than 50 million people globally. Alzheimer’s disease accounts for 60-70% of all cases. The industry’s growth will be assisted by an increasing focus on targeted therapeutics and the huge development of personalized medical treatment regimens for people suffering from CNS illnesses. Thus, this factor boosts market growth.
Higher Technological Advancements of Precision Medicine
Several innovations and the wide availability of new technology are the major factors for the market growth. For instance, the Cleveland Clinic extended its advanced genomic testing platform as the standard of care for patients who have cancer in 2021. This extended capability to test tumor samples includes whole-exome sequencing, analyses of all the parts of DNA in the genes responsible for making proteins in the body, and RNA sequencing. Thus, this factor boosts market growth.
Precision medicine is an innovative medical approach that leverages the interplay of environmental, genetic, and behavioral factors to enhance disease prevention, diagnosis, and treatment. By harnessing this approach, it becomes possible to predict an individual’s susceptibility to certain illnesses, track disease progression, and tailor prescription medicine accordingly. Precision medicine also finds extensive application in detecting chromosomal abnormalities in fetuses, guiding therapy for chronic diseases, and assessing the risk of genetic disorders. Through reducing time, cost, and failure rates in pharmaceutical clinical studies, precision medicine offers transformative potential in healthcare.
The Prominent Key Players Operating in the Precision Medicine Market Include:
- Moderna, Inc. (U.S.)
- Personalis, Inc. (U.S.)
- CureVac SE (Germany)
- Celldex Therapeutics (U.S.)
- BioNTech SE (Germany)
- Advaxis, Inc. (U.S.)
- Agenus Inc. (U.S.)
- Immatics Biotechnologies GmbH (Germany)
- Gritstone Oncology (U.S.)
- ImmunityBio, Inc. (U.S.)
- bioMérieux SA (France)
- Bayer AG (Germany)
- Pfizer Inc. (U.S.)
- GSK plc (U.K.)
- Hoffmann-La Roche Ltd. (Switzerland)
Browse a Detailed Summary of the Global Precision Medicine Research Report @ https://www.databridgemarketresearch.com/reports/global-precision-medicine-market?Shri
Global Precision Medicine Market Scope
Application
- Diagnostics
- Therapeutics
- Others
Technologies
- Pharmacogenomics
- Point-of-Care Testing
- Stem Cell Therapy
- Pharmacoproteomics
- Others
Indication
- Oncology
- Central Nervous System (CNS) Disorders
- Immunology Disorders
- Respiratory Disorders
- Others
Drugs
- Alectinib
- Osimertinib
- Mepolizumab
- Aripiprazole Lauroxil,
- Others
Route of Administration
- Oral
- Injectable
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Media Contact
Sopan Gedam
Organization: Data Bridge Market Research
Phone: +1-888-387-2818
Email: sales@databridgemarketresearch.com
Web: www.databridgemarketresearch.com